Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Roussou M, Tasidou A, Dimopoulos MA, Kastritis E, Migkou M, Christoulas D, Gavriatopoulou M, Zagouri F, Matsouka C, Anagnostou D, Terpos E. Roussou M, et al. Among authors: matsouka c. Leukemia. 2009 Nov;23(11):2177-81. doi: 10.1038/leu.2009.130. Epub 2009 Jul 9. Leukemia. 2009. PMID: 19587705 No abstract available.
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.
Dimopoulos MA, Kastritis E, Christoulas D, Migkou M, Gavriatopoulou M, Gkotzamanidou M, Iakovaki M, Matsouka C, Mparmparoussi D, Roussou M, Efstathiou E, Terpos E. Dimopoulos MA, et al. Among authors: matsouka c. Leukemia. 2010 Oct;24(10):1769-78. doi: 10.1038/leu.2010.175. Epub 2010 Aug 26. Leukemia. 2010. PMID: 20739955
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit.
Dimopoulos MA, Roussou M, Gavriatopoulou M, Fotiou D, Ziogas DC, Migkou M, Panagiotidis I, Eleutherakis-Papaiakovou E, Kanellias N, Psimenou E, Marinaki S, Bacharaki D, Mparmparoussi D, Matsouka C, Giannouli S, Terpos E, Kastritis E. Dimopoulos MA, et al. Among authors: matsouka c. Blood Cancer J. 2017 Jun 16;7(6):e571. doi: 10.1038/bcj.2017.49. Blood Cancer J. 2017. PMID: 28622304 Free PMC article. Clinical Trial. No abstract available.
Waldenström's macroglobulinemia.
Dimopoulos MA, Galani E, Matsouka C. Dimopoulos MA, et al. Among authors: matsouka c. Hematol Oncol Clin North Am. 1999 Dec;13(6):1351-66. doi: 10.1016/s0889-8588(05)70130-1. Hematol Oncol Clin North Am. 1999. PMID: 10626154 Review.
Treatment of Waldenstrom's macroglobulinemia with thalidomide.
Dimopoulos MA, Zomas A, Viniou NA, Grigoraki V, Galani E, Matsouka C, Economou O, Anagnostopoulos N, Panayiotidis P. Dimopoulos MA, et al. Among authors: matsouka c. J Clin Oncol. 2001 Aug 15;19(16):3596-601. doi: 10.1200/JCO.2001.19.16.3596. J Clin Oncol. 2001. PMID: 11504741 Clinical Trial.
41 results